CXCL12 and colorectal carcinoma: β-hydroxybutyrate levels are reduced in human CRC, whereas increased ketogenesis inhibits KLF5 expression in CAFs by suppressing histone deacetylase 1, causing the downregulation of C-X-C motif chemokine ligand 12 (CXCL12).